Contents

Search

acellular pertussis vaccine/diphtheria toxoid/poliovirus vaccine inactivated/tetanus toxoid (Quadracel, DTaP-IPV, Kinrix)

combined diphtheria, tetanus toxoid, acellular pertussis & inactivated poliovirus vaccine Indications: - 5th dose of the DTaP series - 4th dose of the IPV series - children aged 4-6 years are eligible for the new vaccine if they received DTaP (Infanrix) or DTaP-Hepatitis B-IPV (Pediarix) as the 3 three doses & DTaP (Infanrix) as the 4th dose

General

vaccine pharmacologic combination

References

  1. Food and Drug Administration. Product approval information: package insert. Kinrix (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) http://www.fda.gov/cber/products/kinrix.htm
  2. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose MMWR October 3, 2008 / 57(39);1078-1079 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5739a4.htm
  3. Liang J, Wallace G, Mootrey G Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose. MMWR. September 4, 2015 / 64(34);948-949 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a5.htm
  4. Sanofi Pasteur Quadracel. Full Prescribing Information http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf

Components

acellular Pertussis vaccine (Repevax) diphtheria toxoid polio virus vaccine, inactivated (IPOL, IPV, Poliovax, Salk vaccine) tetanus toxoid